Table 1.
STAT3 activators.
Name | Mechanism | Cancer Type | Ref. |
---|---|---|---|
Hsp90 | Chaperone activity via interaction with STAT3 N-terminal region | Hep3B cells | [37] |
STIP1 | Stabilization of JAK2 through its N-terminal domain, thereby promoting STAT3 phosphorylation, signal transduction and JAK2-HSP90-STAT3 complex assembly | MDAH2774, SKOV3 and ARK2 cells, primary ovarian tissues | [38] |
STAP-2 | Modulation of STAT3 activity upon phosphorylation by BRK | HeLa, MCF-7 and T47D cells | [39] |
FGFR | Induction of STAT3 phosphorylation on tyrosine residues, nuclear translocation and activation of STAT3 target genes | HeLa and SUM-52PE cells | [40] |
14-3-3ζ | Interacts with and prevents pSTAT3 Ser727 dephosphorylation by PP2A phosphatase | Multiple myeloma cells | [41] |
MAGEC2 | Interacts with and inhibits STAT3 polyubiquitination and proteasomal degradation | Human (A375) and mouse (B16) melanoma cell lines | [42] |
Importin 3α | Binding to the nuclear localization sequence in the coiled-coil domain of unphosphorylated STAT3 | HeLa and Hep3B cells | [43] |
Importin 5α | Binding to tyrosine phosphorylated STAT3 at the N-terminal domain and maintenance of appropriate conformation | HepG2, MCF7 and HeLa cells | [44] |
LANA | Interaction with STAT3 C-terminal domain and increased STAT3 transcriptional activity | KSHV-negative B lymphoma, DG75 and KSHV-positive BC3 cells | [45] |
EBNA2 | Increased STAT3 DNA-binding activity | HeLa cells | [46] |
ARL2/BART | ARL2-GTP-BART complex is critical for STAT3 activation and nuclear translocation | Hep3B and HeLa cells | [47] |
ARL3 | Interaction with STAT3 DNA-binding domain and C-terminal domain, with consequent STAT3 phosphorylation | HeLa cells | [48] |
Y14 | Association with STAT3 C-terminal domain and positive regulation of STAT3 function | Hep3B cells | [49] |
PASD1 | Impairment of nuclear STAT3 dephosphorylation by TC45 | HeLa cells, HeLa-derived xenografts in nude mice | [50] |
PELP1 | Increases STAT3 phosphorylation on Ser727 residue, facilitates STAT3 recruitment/retention in the target gene promoters | HeLa and MCF-7 cells | [51] |
JAB1 | Increases unphosphorylated STAT3 DNA-binding activity | Colo205 colon cancer cells | [52] |
Progranulin | Regulation of STAT3 phosphorylation, nuclear translocation and transcriptional activity | TNBC cell lines. Primary breast cancer samples |
[53] |
CRIF1 | Association with STAT3 C-terminal coiled-coil domain and positive regulation of STAT3 transcription activity | HeLa, HCT-116, SNU387 and MDA-MB 468 cells | [54] |
Binding and suppression of the androgen receptor transcription activity and coactivation of STAT3 | CWR-R1 cells and surgical specimens of prostate | [55] | |
EGFR | Acts as a transcriptional co-activator of STAT3 | Panc-1 and Colo-357 pancreatic cancer cell lines | [56] |
p300/CREB | Regulation of Lys 685 acetylation, critical for STAT3 to form stable dimers and required for DNA binding | HeLa, MCF-7 and HepG2 cells | [21,57] |
NcoA/SRC1a | Associates with p300/CBP and acts as a cofactor to potentiate STAT3 transcriptional activity | HepG2 cells | [58] |
HDAC3 | Modulation of STAT3 Lys685 acetylation and Tyr705 phosphorylation | Ly3 and DHL2 DLBCL cell lines | [59] |
TOM20 | Regulates STAT3 mitochondrial import and oncogenic functions | Human pancreatic cell lines. BxPC-3-and MIA PaCa-2-derived xenografts in nude mice |
[60] |
TNBC = Triple-Negative Breast Cancer; DLBCL = Diffuse Large B-Cell Lymphoma.